Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATOX1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |
mRNA | FAM175A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
mRNA | MCRIP2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
mRNA | CXCL9 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
mRNA | ALG2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
mRNA | FBXO25 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | NCKAP1L | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0009 |
mRNA | CCT3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
mRNA | SLC4A1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
mRNA | PIP5K1A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |